Literature DB >> 7613559

Dose response studies. II. Analysis and interpretation.

S J Ruberg1.   

Abstract

The primary focus of this paper is to examine analysis strategies for parallel, randomized dose response studies with particular emphasis on identifying the minimum effective dose. Such studies have become a standard for drug development in the pharmaceutical industry. Particular attention is paid to ANOVA followed by multiple comparison procedures with some additional discussion of the utility or regression models. When there are three or fewer dose groups and a placebo in a study, ANOVA techniques are preferred; with a larger number of dose groups, regression analysis has greater utility and reliability. Analysis of factorial dose response studies is reviewed only slightly as this is an emerging area of interest, and further development is necessary.

Mesh:

Year:  1995        PMID: 7613559     DOI: 10.1080/10543409508835097

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  7 in total

1.  Statistical Methods for Selecting Maximum Effective Dose and Evaluating Treatment Effect When Dose - Response is Monotonic.

Authors:  Maiying Kong; Shesh N Rai; Roberto Bolli
Journal:  Stat Biopharm Res       Date:  2014-01-02       Impact factor: 1.452

2.  Exercise effects on depressive symptoms and self-worth in overweight children: a randomized controlled trial.

Authors:  Karen H Petty; Catherine L Davis; Joseph Tkacz; Deborah Young-Hyman; Jennifer L Waller
Journal:  J Pediatr Psychol       Date:  2009-02-16

3.  Physical activity in depressed elderly. A systematic review.

Authors:  Gioia Mura; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-07-12

4.  Spline-based procedures for dose-finding studies with active control.

Authors:  Hans-Joachim Helms; Norbert Benda; Jörg Zinserling; Thomas Kneib; Tim Friede
Journal:  Stat Med       Date:  2014-10-16       Impact factor: 2.373

5.  Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes.

Authors:  Robert R Henry; Juan P Frias; Brandon Walsh; Sharon Skare; John Hemming; Colleen Burns; Thomas A Bicsak; Alain Baron; Mark Fineman
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

6.  Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review.

Authors:  Maznah Ismail; Abdulsamad Alsalahi; Mustapha Umar Imam; Der Jiun Ooi; Huzwah Khaza'ai; Musheer A Aljaberi; Mad Nasir Shamsudin; Zulkifli Idrus
Journal:  Nutrients       Date:  2020-02-18       Impact factor: 5.717

7.  Pharmacometrics meets statistics-A synergy for modern drug development.

Authors:  Yevgen Ryeznik; Oleksandr Sverdlov; Elin M Svensson; Grace Montepiedra; Andrew C Hooker; Weng Kee Wong
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.